To aid in the diagnosis of BCa, a range of urine tests have been developed including the bladder tumour antigen (BTA) test, nuclear matrix protein 22 (NMP22), urinary bladder cancer antigen (UBC), and fibrin degradation products (FDP). The gene discussed is NUMA1; the disease is urinary bladder neoplasm.